Holen Sie sich die Stockscreener-App
3.90
0.26%
-0.01
Handel nachbörslich:
4.04
0.14
+3.59%
Schlusskurs vom Vortag:
$3.91
Offen:
$4.07
24-Stunden-Volumen:
36,816
Relative Volume:
0.41
Marktkapitalisierung:
$38.27M
Einnahmen:
$442.00K
Nettoeinkommen (Verlust:
$-30.46M
KGV:
-0.8744
EPS:
-4.46
Netto-Cashflow:
$-27.47M
1W Leistung:
-5.34%
1M Leistung:
+22.26%
6M Leistung:
-26.55%
1J Leistung:
-45.38%
1-Tages-Spanne:
$3.84
$4.09
1-Wochen-Bereich:
$3.665
$4.22
52-Wochen-Spanne:
$2.2801
$7.00
Clene Inc Stock (CLNN) Company Profile
Firmenname
Clene Inc
Sektor
Branche
Telefon
801-676-9695
Adresse
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Vergleichen Sie CLNN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
3.90 | 38.27M | 442.00K | -30.46M | -27.47M | -4.46 |
|
KHC
Kraft Heinz Co
|
26.61 | 31.47B | 25.43B | 2.66B | 3.03B | 2.19 |
|
JBS
Jbs N V
|
14.21 | 30.77B | 88.95B | 2.16B | 374.50M | 0.9748 |
|
GIS
General Mills Inc
|
53.19 | 29.84B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
79.86 | 28.25B | 12.63B | 1.38B | 863.00M | 3.96 |
|
MKC
Mccormick Co Inc
|
77.17 | 20.28B | 6.68B | 792.60M | 774.40M | 2.94 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-04 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-07-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-09-28 | Eingeleitet | Oppenheimer | Outperform |
Clene Inc Aktie (CLNN) Neueste Nachrichten
Best Nanotechnology Stocks To Add to Your WatchlistJune 16th - MarketBeat
Clene Regains Nasdaq Compliance as of June 2025 - TipRanks
Top Nanotechnology Stocks Worth WatchingJune 17th - MarketBeat
Best Nanotechnology Stocks To Keep An Eye OnJune 15th - MarketBeat
Nanotechnology Stocks To Watch NowJune 14th - MarketBeat
Best Nanotechnology Stocks To Follow Now – June 13th - Defense World
Best Nanotechnology Stocks To Follow NowJune 13th - MarketBeat
Clene Inc. (NASDAQ:CLNN) Receives $40.00 Average Target Price from Analysts - Defense World
Promising Nanotechnology Stocks To ResearchJune 11th - MarketBeat
Nanotechnology Stocks To ResearchJune 8th - MarketBeat
Clene (NASDAQ:CLNN) Trading Down 0.7% – Should You Sell? - Defense World
Clene Inc. CEO to Share Company Updates at Investor Summit Virtual - citybuzz -
Clene Inc. Chief Executive Officer Rob Etherington to Present at - GuruFocus
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025 | CLNN Stock News - GuruFocus
Clene CEO Rob Etherington Set to Reveal Company Updates at Investor Summit Virtual Conference - Stock Titan
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025 - The Globe and Mail
Nanotechnology Stocks To Follow NowJune 9th - MarketBeat
Clene Inc. (CLNN) Executives to Host Meeting with Maxim | CLNN S - GuruFocus
Clene management to meet with Maxim - TipRanks
Nanomedicines Market Booming Worldwide: Growth Trends, - openPR.com
Clene Inc. shareholder General Resonance sells $2,472 in stock - Investing.com
Best Nanotechnology Stocks To Follow Today – May 31st - Defense World
Clene Inc. shareholder General Resonance sells $2,472 in stock By Investing.com - Investing.com UK
Clene Inc.: General Resonance LLC sells $1,148 in common stock By Investing.com - Investing.com Nigeria
Clene Inc.: General Resonance LLC sells $1,148 in common stock - Investing.com
Clene inc. sees $1,089 stock sale by major shareholder - Investing.com South Africa
Clene Approves Stock Plan Amendment at Annual Meeting - TipRanks
Clene stock touches 52-week low at $2.5 amid market challenges By Investing.com - Investing.com South Africa
Clene stock touches 52-week low at $2.5 amid market challenges - Investing.com Australia
Brokerages Set Clene Inc. (NASDAQ:CLNN) Target Price at $40.00 - Defense World
Clene eyeing regulatory submission for CNM-Au8 in ALS by year’s end - ALS News Today
Clene Inc. (CLNN) Reports Q1 Loss, Lags Revenue Estimates - MSN
HC Wainwright Issues Positive Forecast for Clene Earnings - Defense World
Roth Capital Has Optimistic Outlook of Clene Q2 Earnings - Defense World
Benchmark Lowers Clene (NASDAQ:CLNN) Price Target to $33.00 - Defense World
D. Boral Capital Reaffirms Buy Rating for Clene (NASDAQ:CLNN) - Defense World
Clene Inc. Reports Reduced Losses Amid Strategic Cost-Saving Measures - TipRanks
Promising Nanotechnology Stocks To Watch Now – May 7th - The AM Reporter
Clene Inc. Advances CNM-Au8 Treatment for ALS, Reports Promising Q1 Results - citybuzz -
Clene Inc. Advances CNM-Au8 Toward Potential Accelerated Approval for ALS - citybuzz -
Clene’s Strategic Financial Management and Promising Clinical Developments Drive Buy Rating - TipRanks
Clene (CLNN) Maintains Buy Rating Despite Price Target Reduction | CLNN Stock News - GuruFocus
Clene (CLNN) Stock Rating and Price Target Maintained at Buy | C - GuruFocus
Renaissance Technologies LLC Invests $96,000 in Clene Inc. (NASDAQ:CLNN) - Defense World
Clene Inc. to Showcase Neurodegenerative Research at D. Boral Capital Global Conference - citybuzz -
Clene (CLNN) Reports Decline in Cash Reserves | CLNN Stock News - GuruFocus
Clene Faces Nasdaq Delisting Risk Amid Regulatory Pursuits - TipRanks
Clene (CLNN) Exceeds Revenue Expectations and Advances ALS Research | CLNN Stock News - GuruFocus
Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights - The Manila Times
Clene Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference | CLNN Stock News - GuruFocus
Clene Inc. SEC 10-Q Report - TradingView
Finanzdaten der Clene Inc-Aktie (CLNN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Clene Inc-Aktie (CLNN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| General Resonance LLC | 10% Owner |
Jun 02 '25 |
Sale |
4.12 |
600 |
2,473 |
708,592 |
| General Resonance LLC | 10% Owner |
May 30 '25 |
Sale |
2.80 |
410 |
1,148 |
709,192 |
| General Resonance LLC | 10% Owner |
May 29 '25 |
Sale |
2.73 |
410 |
1,119 |
709,602 |
| General Resonance LLC | 10% Owner |
May 28 '25 |
Sale |
2.60 |
420 |
1,090 |
710,012 |
| General Resonance LLC | 10% Owner |
May 27 '25 |
Sale |
2.45 |
420 |
1,029 |
710,432 |
| General Resonance LLC | 10% Owner |
Mar 19 '25 |
Sale |
4.40 |
1,400 |
6,160 |
710,852 |
| General Resonance LLC | 10% Owner |
Mar 18 '25 |
Sale |
4.45 |
1,333 |
5,932 |
712,252 |
| MATLIN DAVID J | Director |
Sep 30 '24 |
Buy |
4.75 |
92,307 |
438,458 |
444,491 |
| Mortenson Mark | Chief Science Officer |
Sep 30 '24 |
Buy |
4.75 |
20,512 |
97,432 |
28,949 |
| Etherington Robert Dee | Chief Executive Officer |
Sep 30 '24 |
Buy |
4.75 |
10,000 |
47,500 |
40,149 |
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):